Skip to main content

Posts Tagged ‘pharma’

Fortune 500 Pharma And Biotech Companies

  Eleven pharma and biotech companies appeared on this year’s Fortune 500 list. While there are additional organizations (e.g., Procter & Gamble) that manufacturer medicines on the list, they weren’t classified as pharmaceutical companies in the ranking. These are the drug companies that made this year’s list, ranked by total annual revenue: 

A Quick Look At Google Search For Work

Photo Credit: Maglara / Shutterstock.com My colleague, Beth Martin, wrote a great blog post today about the benefits of using Google Search for Work. What is Google Search for Work, you ask? Think of it as using Google to search the Internet, except that you search your company’s systems instead. Take a look at the infographic below, which […]

Are Email Attachments Subject To 21 CFR Part 11?

  On Thursday, April 23, 2015, we delivered a webinar on 21 CFR Part 11, based on a recent blog series. During the Q&A session at the end, someone asked the following question: In one of the initial slides, you mentioned that documents attached to emails do not fall under 21 CFR Part 11. Could […]

Which Companies Made CIO’s Top 100 List?

  CIO, a leading news source published by IDG Enterprise and geared towards IT leaders, announced their list of the top 100 companies who “have distinguished themselves by creating business value through the innovative use of technology.” The magazine also selected five CIOs for the 2015 Hall of Fame. One of the five happens to […]

AstraZeneca: A Digital Transformation Leader

  After sitting through a week’s worth of presentations and case studies related to digital transformation, I can’t help but think about the deep changes AstraZeneca has gone through in recent years. It’s been a massive feat with extraordinary outcomes, and they’re still not done making positive changes throughout their operations. AstraZeneca’s goal was to […]

Migrating Legacy Clinical Data From CRO To Sponsor

  Sponsors are known to work with multiple contract research organizations (CROs). And, depending on the agreement in place with each CRO, data can be captured in either the sponsor’s systems (CDMS and/or EDC) or the CRO’s. If the data is stored in CRO databases, there may come a time when it needs to be […]

How Much System Access Should We Give An FDA Inspector?

  On Thursday, April 23, 2015, we delivered a webinar on 21 CFR Part 11, based on a recent blog series. During the Q&A session at the end, someone asked the following question: The Scope section requires access to electronic records and signatures (ER/ES) at all times. What if the electronic system used by a […]

Patient Education Can Give Pharma A Lift

  If you really think about it, it’s quite astonishing that Viagra sales in 2014 grew 47% in China, a country in which discussing sexual health-related topics has long been considered taboo. So, what caused this surge in sales?

Top 5 Life Sciences Blog Posts From May 2015

  Now that June is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in May – they’re ranked in order of popularity, with number one being the most viewed piece. 

Can Clinical Trial Software Be Validated In The Cloud?

  We recently discussed customizing and configuring clinical trial software that is hosted in the cloud. For the final post in our “cloud fact or fiction” blog series, we’ll discuss the hot topic of validation. 

Can Configurations And Customizations Happen In The Cloud?

  As you may have read in our most recent “cloud fact or fiction” post, we confirmed that companies have the ability to perform system administration activities for solutions hosted in the cloud. Let’s now tackle configurations and customizations. 

Eli Lilly CEO Breaks Down 5 Misconceptions About Pharma

  The pharma industry undoubtedly gets a bad rap. “Drug companies charge too much.” “They are only in it for themselves.” And it goes on and on. But are these accusations truly justified? In a recent Forbes opinion piece, John Lechleiter, Chairman, President, and Chief Executive Officer of Eli Lilly, brilliantly debunks the more common […]

Load More